Citigroup »

Design Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 4.8k 2.65
2023-09-30 $1.8k 774 2.35
2023-03-31 $20k 3.4k 5.77
2022-12-31 $1.1M 110k 10.26
2022-09-30 $573k 34k 16.72
2021-12-31 $604k 28k 21.42